tykhr
sign in
free sign up
Brainstorm Cell Therapeutics Inc
Biotechnology
Healthcare
BCLI
5.31 M shares
NASDAQ US
traded
27 Mar 2025
listed
no
open
1.34
52 week high
9.30
high
1.42
52 week low
1.13
low
1.34
growth
-80.26 %
previous Close
1.40
P/E ratio
market cap
11.81 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-2.71 M
-6.57 %
eps
0.00 %
-1.00 %
eps surprise
27.14 %
net profit margin
-270800000.00 %
696.00 %
operating incoming
-3.05 M
-2.21 %
net change in cash
-3.30 M
-222.64 %
cash on hand
168 K
-95.16 %
cost of revenue
0.00 %
top